EDIGENE
EdiGene is dedicated to the development of genome editing technology for human health. Genome editing technology enables the targeted modification of genetic information in human cells, including gene knockout, knock-in and targeted mutations. They aim at providing the high quality products and services for the patients, the pharmaceutical industry, and the scientific research community with the most advanced genome editing technology.EdiGene innovates and applies genome editing technology to developing human therapeutic products. Their therapeutic approach is to treat diseases at the molecular level, making gene therapy safer and more effective.
EDIGENE
Industry:
Biotechnology Genetics Health Care
Founded:
2015-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.edigene.com
Total Employee:
51+
Status:
Active
Contact:
010-8073 3899
Email Addresses:
[email protected]
Total Funding:
179.66 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Apache Mobile Non Scaleable Content Euro DigiCert SSL Pound Sterling
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Color
Color is a complete platform for healthcare delivery.
CureGenetics
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Qitan Technology
Qitan Technology is a Developer of a genome sequencing technology.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
BioTrack Capital
BioTrack Capital investment in Series B - EdiGene
3H Health Investment
3H Health Investment investment in Series B - EdiGene
Loyal Valley Capital
Loyal Valley Capital investment in Series B - EdiGene
Sequoia Capital China
Sequoia Capital China investment in Series B - EdiGene
Alwin Capital
Alwin Capital investment in Series B - EdiGene
Sherpa Venture Capital
Sherpa Venture Capital investment in Series B - EdiGene
Huagai Capital
Huagai Capital investment in Series B - EdiGene
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - EdiGene
IDG Capital
IDG Capital investment in Series B - EdiGene
Kunlun Capital
Kunlun Capital investment in Series B - EdiGene
Official Site Inspections
http://www.edigene.com
- Host name: 47.95.119.17
- IP address: 47.95.119.17
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "EdiGene"
EdiGene - Crunchbase Company Profile & Funding
Organization. EdiGene . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. EdiGene is a biotechnology company that develops genome editing technologies. ...See details»
EdiGene Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Nov 1, 2024 Explore EdiGene Inc. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 12 news, and 13 literature, Disease Domain:Hemic and Lymphatic Diseases, …See details»
EdiGene Company Profile | Management and Employees List
EdiGene Profile and History. EdiGene is a clinical-stage biotechnology company focused on leveraging the cutting-edge genome editing technologies to accelerate drug discovery and …See details»
EdiGene - The Org
EdiGene Inc. provides one of the biggest KO cell line libraries with competitive price and services with SOP for any kind of genome editing projects.See details»
EdiGene Inc.: Contact Details and Business Profile
EdiGene is a clinical-stage company focused on translating gene-editing technologies into transformative genetic medicines for patients with significant unmet medical needs. Anchored …See details»
Org Chart EdiGene - The Official Board
The organizational chart of EdiGene displays its 11 main executives including Yajun Si, Yang Lei, Jiahong Li and Ming Jin. Toggle navigation The Official Board. Search. Search. Search by …See details»
EdiGene Company Profile 2024: Valuation, Funding & Investors
EdiGene General Information Description. Operator of a clinical-stage biotechnology company focused on leveraging cutting-edge genome editing technologies to accelerate drug discovery …See details»
EdiGene Inc. - LinkedIn
EdiGene Inc. | 1,511 followers on LinkedIn. Edit the Code of Life, Creating Transformative Solutions for Serious Diseases. | EdiGene is a clinical-stage company focused on translating …See details»
EdiGene - Overview, News & Similar companies | ZoomInfo.com
EdiGene contact info: Phone number: (617) 682-5731 Website: www.edigene.com What does EdiGene do? EdiGene is a clinical-stage biotechnology company focused on leveraging the …See details»
EdiGENE Company Profile - Office Locations, Competitors ... - Craft
EdiGENE has 5 employees at their 1 location and $143.5 m in total funding,. See insights on EdiGENE including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
EdiGene - Funding, Financials, Valuation & Investors - Crunchbase
EdiGene is a biotechnology company that develops genome editing technologies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ...See details»
EdiGene Inc. Company Overview, Contact Details & Competitors
Gene-editing Therapies EdiGene focuses on developing transformative genetic medicines using proprietary gene-editing technologies. This innovative approach presents opportunities for …See details»
EdiGene
We would like to show you a description here but the site won’t allow us.See details»
EdiGene - VentureRadar
EdiGene is a global, clinical-stage biotechnology company focused on translating gene editing technologies into transformative therapies for patients with serious genetic diseases and …See details»
EdiGene - Contacts, Employees, Board Members, Advisors & Alumni
EdiGene is a biotechnology company that develops genome editing technologies.See details»
EdiGene - PharmaBoardroom
Apr 12, 2019 EdiGene is a biotechnology company with a mission to translate the cutting-edge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into …See details»
EdiGene Company Profile: Overview and Full News Analysis
EdiGene, Inc. will present getools (gene editing data analysis toolkit) for advanced analytics of DNA and RNA editing efficiency and outcomes for therapeutic development at the American …See details»
Company: EdiGene - CRISPR Medicine
EdiGene is a clinical-stage, gene-editing company, mainly focused on the development of novel therapies for haematopoietic diseases and cancer. The company holds licenses on proprietary …See details»
EdiGene - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 24, 2024 Organization. EdiGene . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 10. Monthly …See details»
EdiGene and Arbor Biotechnologies Announce Worldwide
Feb 8, 2022 EdiGene is a global, clinical-stage biotechnology company focused on translating gene editing technologies into transformative therapies for patients with serious genetic …See details»